Drugs / Amoxicillin-Potassium Clavulanate Combination
last change Oct 2018 re-read 3 minutes ago

Amoxicillin-Potassium Clavulanate Combination

Developed for
pneumonia
Investigated by
Menzies School of Health Research · University of Malaya

Trials 1

2015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT02258763 Nov 2014 → Nov 2017 pneumonia University of Malaya Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Amoxicillin-Potassium Clavulanate Combination ClinicalTrials.gov intervention name — accepted as the source's own label NCT02258763 ↗
Route Oral “Twice a day oral amoxicillin-clavulanate (22.5mg/kg/dose) for 10 days” NCT02258763 ↗